O3R-5671-PRO: Tolerance Study in Healthy Adults

We are evaluating how well healthy adults tolerate single and multiple doses of the new medication O3R-5671-PRO. This study aims to ensure the safety of the drug for future use.

3-6 monthsSafety phase (I)DermatologyInfectious DiseasesInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
SGS Belgium
SGS-Clinical Research CPU
Wilrijk, Belgium
Sponsor: ONCO3R Therapeutics
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.